Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of In-Vitro Cryo Therapeutic Intervention on Human Cellular Samples - Truway Health Cryogenics Pilot Study

NCT07321028 is registered in ClinicalTrials.gov with Truway Health, Inc. as lead sponsor.

NCT NCT07321028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07321028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of In-Vitro Cryo Therapeutic Intervention on Human Cellular Samples - Truway Health Cryogenics Pilot Study
Lead sponsor
Truway Health, Inc.
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
December 10, 2025
Completion date
December 10, 2066
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomechanical injury modeling (in-vitro), blunt force injuries to the extremities (cellular injury model), cellular injury and post-cryogenic recovery, cellular regeneration and repair, cold-induced cellular injury, cryogenic cellular stress, hypothermic tissue stress, osmotic stress injury, post-thaw viability impairment, thermal injury response, tissue damage and recovery pathways